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Abstract
Background: Opioid overdose is a leading cause of death among injection drug users. Over half
of injection drug users report at least one nonfatal overdose during their lifetime. Death from
opioid overdose rarely occurs instantaneously, but rather over the course of one to three hours,
allowing ample time for providing life-saving measures. In response to the prevalence of overdoses
in the U.S., there are a growing number of overdose prevention and naloxone distribution
programs targeting the injection drug using community.
Methods:  We explored injection drug users' experiences with opioid overdose response,
examining differences between overdose responses in which naloxone was and was not used. The
current study is based upon qualitative interviews (N = 31) with clients of the Chicago Recovery
Alliance needle exchange program who had witnessed an overdose in the past six months. The
interviews explored participants' drug use history, personal overdose experiences, and details
concerning their last witnessed overdose. Verbatim transcripts were coded and analyzed
thematically to address major study questions.
Results: Participants were 81% were male, their median age was 38. They reported having injected
a median of 10 years and having witnessed a median of six overdoses in their lifetime. All described
overdoses were recognized and responded to quickly. None of the overdoses resulted in a fatality
and naloxone was successfully administered in 58% of the last witnessed overdoses. Administering
naloxone for the first time was characterized by trepidation, but this feeling dissipated as the
naloxone quickly took effect. Emergency medical personnel were called in 10 of the 31 described
overdoses, including four in which participants administered naloxone. The overwhelming majority
of experiences with police and paramedics were positive
Conclusion:  Overall, our small study found that the overdose prevention efforts build on
extensive knowledge possessed by IDUs. Teaching IDUs how to use naloxone is an effective risk
reduction strategy.
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Background
Opiate overdose is the single greatest cause of mortality
among IDUs in the U.S. [1]. Over half the deaths of heroin
injectors are attributed to opiate overdoses [2], far exceed-
ing the proportion of deaths due to AIDS or other morbid-
ities. As a result, IDUs have an annual mortality rate of
2%, a rate six to twenty times higher than their non-drug
using peers [2]. In addition to the burden of overdose
mortality, IDUs suffer a high prevalence of non-fatal opi-
ate overdose. Studies show the proportion of heroin IDUs
reporting at least one non-fatal overdose in their lifetime
was 48% in San Francisco [3], 42% in New York City [4],
38% in London [5], and 68% in Sydney, Australia [6].
Death from opioid overdose rarely occurs instantane-
ously, but rather over the course of one to three hours,
allowing ample time for providing life-saving measures
[7,8]. Commonly referred to by its trade name, Narcan,
naloxone is an opioid antagonist routinely used by emer-
gency medical personnel to reverse opiate overdose.
Naloxone has no pharmacological effects in the absence
of opioids and is a cost-effective tool for preventing death
and disability from opioid overdose [9]. In the U.S. as
elsewhere, naloxone dispensation is regulated as an
unscheduled prescription drug, meaning that it is not a
dangerous drug but a prescription is required. Training
drug users in appropriate overdose prevention and
response can be beneficial in preventing nonfatal and
fatal overdoses. Following England and Australia, a
number of overdose prevention and naloxone distribu-
tion (OPND) programs have been developed in the U.S.
over the past several years. Preliminary pilot evaluations
have demonstrated feasibility and acceptability among
IDUs [3,10-12]. The current study explores what informed
IDUs' choice in overdose response, comparing responses
that did and did not include naloxone administration.
Methods
Training
CRA has operated a syringe exchange program and con-
ducted HIV prevention outreach with drug users since
1991. An average of 340 drug users are reached weekly
through 16 mobile van and storefront sites. In 1998, a vol-
unteer physician began prescribing and dispensing
naloxone from some of CRA's busier outreach sites, the
first in the U.S. In 2000, CRA expanded these overdose
prevention efforts to all sites. All CRA staff were trained by
a physician in an extensive curriculum that included: basic
opioid neurophysiology; opioid and opioid antagonists
pharmacodynamics; overdose risk factors, prevention,
and symptoms; aspiration prevention; rescue breathing;
naloxone administration; and dosing guidelines.
Trained CRA staff implemented the 30-minute OPND
intervention focused on overdose prevention techniques,
overdose recognition, and response options. Trainings
occurred in small groups or one-on-one. All CRA partici-
pants were offered the training, regardless of injection
drug use status. After participants received the training,
staff collected a brief medical history and administered a
brief post-training checklist that tested participants' reten-
tion of the training. Participants then received a 10 ml
multi-dose vial of naloxone, three sterile intramuscular
syringes, a pocket-sized overdose response and recogni-
tion card, and a naloxone prescription.
Study population and data collection
Purposive sampling was used to recruit IDUs who
exchanged syringes at three of CRA's sites. Eligible partici-
pants were 18 years or older and had witnessed an over-
dose within the past six months. A qualitative researcher
conducted interviews twice weekly over the course of
three months in 2004. During these times, CRA staff
referred individuals to the interviewer if they had report-
edly witnessed an overdose within the previous six
months. This was ascertained in one of several ways: they
requested a naloxone refill; they asked to receive OPND
training; or through casual conversation with staff. The
researcher further verified both study criteria.
If clients seemed relatively articulate for the purposes of a
qualitative interview provided informed consent, the
researcher conducted individual semi-structured qualita-
tive interviews in her car so that confidentiality could be
maintained. The qualitative interview guide explored:
illicit drug use history; overdose experiences; lessons
learned from the OPND training (if appropriate); and
details concerning their last witnessed overdose. Inter-
views ranged in length from 30 to 45 minutes and were
tape-recorded and transcribed. The study was found
exempt from review by the Johns Hopkins Bloomberg
School of Public Health Committee on Human Research
and the Yale School of Medicine Human Investigation
Committee. Respondents received $20 compensation for
their participation.
Data analysis
Two qualitative researchers analyzed the data thematically
in a multi-step process using the constant comparative
method that is central to grounded theory [13]. After read-
ing several interviews for comprehension of interview
content, five interviews were chosen for open coding.
Open coding is a process of reading small segments of text
at a time and making notations in the margins regarding
content or analytic thought, without being constrained by
existing theoretical explanations [13]. The labels applied
in the open coding process were then synthesized into a
code list to remove redundancy and similar labels were
grouped together. The initial theme list closely followed
the in-depth interview instrument as it was quite detailedHarm Reduction Journal 2008, 5:2 http://www.harmreductionjournal.com/content/5/1/2
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in terms of lines of questioning and related probes. The
code list was then used to code all of the interviews. Data
were entered into Atlas-ti version 4.2, a qualitative data
management program, in order to organize all project
coding and memos.
Results
Participants (N = 31) were 81% were male and the
median age was 38, ranging from 21 to 55 yeas old. Par-
ticipants reported having injected a median of 10 years
and 81% injected daily. Participants reported having wit-
nessed a median of six overdoses in their lifetime and
32% had witnessed at least one fatal overdose in their life-
time. None of the overdose events described in this anal-
ysis were fatal. Twenty-two participants had received
OPND training, but only 18 administered naloxone in the
described events.
Overdose response
Participants considered a number of factors in deciding
how to respond. Fear of legal consequences weighed heav-
ily, but was counterbalanced by a desire to safe a life.
Combination of responses
A range of additional revival methods were reported: 10
participants called 911, including four instances when
naloxone was administered; six poured cold water or ice
on the person, including two instance when naloxone was
administered; six hit the person, including three instances
when naloxone was administered; three rubbed the per-
son's sternum, including two instances when naloxone
was administered; and four administered mouth-to-
mouth resuscitation. In five cases, the overdose survivor
was taken to the hospital, including twice when naloxone
was administered.
Use of naloxone
All of the 18 participants who had administered naloxone
had been through the CRA training. In all these cases,
naloxone effectively revived the victim. Participants
reported that they had been present at a median of two
overdose events in which naloxone had been used. In
describing the first time that they administered naloxone,
key themes were that of trust in oneself and naloxone.
I did think of the Narcan but I didn't want to use it because
I wasn't sure if I administered it but I didn't do it correctly,
or if I'd have killed him ... And then I thought, well, maybe
if he dies and I didn't do anything... So, I injected him once
with it..." (40 year old woman)
After using naloxone the first time and seeing rapid and
positive results, participants gained a sense of comfort.
When I know what's happening I feel pretty comfortable
now. As long as there's Narcan somewhere in the house, I
feel like I can deal with it. I get really scared, of course, and
start panicking but I don't panic in a way that' s making me
not think straight. (44 year old man)
Advance planning is an important step in having
naloxone accessible and available when needed, as
emphasized in the CRA training. A young man who lives
with several IDUs described the accessibility of naloxone
in their house.
We keep it in needles in the house. We keep it all ready...
They give us special needles, larger ones for muscles. We
keep one of those in every room of people who use and in the
bathroom. (27 year old man)
Participants were overwhelmingly pleased with their abil-
ity to administer naloxone during an overdose. As one 55
year old man said, "You can save someone and you don't
have to worry about people dying on you anymore. I've
had lots of friends die. Now you know that you can save
'em if you have narcan."
Revivals without naloxone
Thirteen participants did not use naloxone in response to
the overdose. In absence of the drug, numerous responses
were employed successively until revival. A 26 year old
man's description is typifies this scenario.
I knew something's wrong so I start slappin' him and tryin'
to wake him up and he wasn't waking up, so...then I drove
to the Hospital and I pulled into the parking lot. I didn't
want to do it because, for one, I was high as hell myself and
I didn't want to have to bring him in there with a car full
of heroin... For 10 minutes he was startin' to get very cold
and his face was turnin' blue and I took water and I threw
it in his face and he kind of moved around a little bit so I
slapped him in his face and started shakin' him and he
finally came out of it.
A 36 year old woman tried CPR before calling 911 when
her friend overdosed in her bathroom. She took the CRA
training a month after this occurred.
A girlfriend of mine went into the bathroom and she come
out and like five minutes later she fell out on the floor and
turned blue. CPR wasn't working so we had to call 911.
They came and gave her the injection of narcan and it
brought her out of it.
One participant who had naloxone on hand decided to
revive his friend through mouth-to-mouth resuscitation
because she was afraid of using the naloxone. She was
unsure if it would work.Harm Reduction Journal 2008, 5:2 http://www.harmreductionjournal.com/content/5/1/2
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Well first I went to him and I started mouth to mouth like
I always do because I see the pale face and that scared me.
I was just focusing on him breathin' and he started breath-
ing again, and every time I gave him a breath of air, he
started breathing again. (44 year old man)
Factors influencing contacting emergency personnel
Participants described a range of thoughts and emotions
that influenced their decision to call 911. When asked
about this decision process, participants unanimously
began their response with expressing their fear of police
accompaniment and the possibility of arrest. Past negative
experiences with medical personnel, albeit less frequently
reported than fear of police, was also mentioned as a bar-
rier. The following excerpts describe participants' struggle
between calling 911, their desire to help their friends, and
other issues of issues.
I'm thinkin', 'Oh, my god, I'm going to jail. Oh, my god,
my friend's gonna die.' I'm worried about him, I don't want
him to die, but yet I'm looking at the legal aspect. I got, like,
20 bags of dope in the car. I don't want to go to jail. (39
year old man)
What am I gonna tell the cops? What am I gonna tell my
mom? ...All those questions that are runnin' through your
head. What's gonna happen? Are we all gonna get arrested
because of this? Is he gonna die? What am I gonna tell his
parents? All sorts of crazy shit, because I've known him for
a long time and thought, if this happens with me and then
his family's gonna blame me. I had all these things going
through my head but my main concern was tryin' to get him
to wake back up. (42 year old man)
One man who did not have naloxone available felt he had
no choice but to call 911 because that was the best way to
help his friend.
I'd rather have the person live. I really couldn't live with
myself if I didn't call and the guy died. I had the chance to
call them and he would live. I wouldn't be able to survive,
you know, that would really bug me. (44 year old man)
Paramedic's reactions to recent overdose
Half of those who called 911 reported positive interac-
tions with emergency responders. A participant who both
administered naloxone and called 911 received positive
feedback.
Well, when the ambulance got there I said, 'You better give
him a little more [naloxone], man.' They asked me about
how I got naloxone and I told them about the train-
ing...they said I did a good job. (38 year old man)
But a few did have negative experiences with paramedics
either in the way in which they were treated or expressed
doubt at participants' ability to administer naloxone.
I told them what I did and they were kind of nasty to me.
They said that I shouldn't have administered something,
that I'm not trained in it, that I'm not a paramedic. I said,
'Well, what should I do, let him die?' That's when he told
me I wasn't – he kinda blew on me about that. (55 year
old man)
Police accompanied paramedics in four instances, result-
ing in no arrests and no negative interactions. As reported
by a 44 year old man, "The police were pretty cool. I told
him what I did and he said, 'You probably saved his life.
He was cool about it."'
Discussion
The current study is the first to qualitatively explore how
IDUs' responded to an overdose and their feelings about
their choices in the context of an overdose prevention and
naloxone distribution program. Regardless of the
responses employed, results demonstrate individuals'
desire to and ability to help their peers. Naloxone was well
received and utilized by the majority of those trained. Any
fear of initial use dissipated quickly as naloxone took
effect, although fear did prevent one participant from
using the naloxone. Fear of administering naloxone for
the first time should be addressed in OPND trainings.
OPND trainings build upon participants' extensive over-
dose experience. Ultimately, participants were proud to be
able to save someone's life.
Although rarely reported, several participants reported
having performed incorrect responses to overdose, such as
pouring ice or hitting on the victim. Participants' reliance
on such methods will hopefully diminish over time and
as they have seen naloxone in use. When participants
return for their naloxone refills, it is important for staff to
ask questions about overdose response and address these
types of myths and any other issues that arise.
Administering naloxone is a component of the caretaking
role that many IDUs have within their injection networks
[14]. Naloxone distribution programs build on IDUs' nat-
ural helping roles and extend the benefits of such risk
reduction programs beyond their hours of operation and
their geographic location. In the context of general resist-
ance to interface with both hospital and legal/law enforce-
ment institutions, such trainings provide a positive
alternative. Of course the inherent downside to this self
care is the potential for increasing IDUs' distance from
"legitimate" health care services. But OPND trainings are
an opportunity to address the importance of both self carePublish with BioMed Central    and   every 
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and promoting the use of and referrals to important
health and social services.
OPND trainings can help people respond appropriately to
overdose events when they are wary of calling 911. The
extent of this fear and its effects on overdose response has
been documented in several studies [6-15]. We found that
35% of participants did call 911 although extensive fear of
police accompaniment was expressed. Several positive
and no negative police interactions were reported and
most interactions with paramedics were positive. Educat-
ing first responders, such as emergency medical personnel
and police, about overdose prevention programs is an
important component of OPND programs and could
reduce negative experiences between overdose bystanders
and first responders.
The current study is subject to several limitations. The
analysis is not generalizable beyond this small sample of
CRA participants. As characteristic of many qualitative
studies, the sample was not randomly; rather, individuals
were selected based not only on inclusion criteria but also
on the basis of judgements about individuals' ability to
articulate their experiences. Lastly, all data collection was
completed prior to analysis, which limited the ability to
explore emergent themes as they arose during "real time
[16]."
The study points to needed future research. As OPND pro-
grams continue to be established and existing programs
grow in the U.S., long-term and more rigorous research is
needed. Although existing research is favourable, larger
studies with longer-term outcomes are needed to truly
establish effectiveness in the far-reaching goal of reducing
fatal opiate overdose rates. At this time, only one such
longitudinal study of has been conducted in Australia and
results indicated OPND training was associated with over-
dose reductions [17].
The current study is the first qualitative study among a
small body of research that evaluates OPND programs.
The study indicates the potential benefits of these pro-
grams and underscores the need for more rigorously
designed evaluations. In this small sample, we found that
participating in the OPND training provided IDUs with a
sense of dignity – both through being educated about
such a salient issue in their lives and having the opportu-
nity to intervene safely and effectively to save someone's
life. Overdose prevention education and naloxone distri-
bution provide IDUs with the tools to be effective first
responders. OPND trainings not only provide the neces-
sary tools for effective overdose response to reduce fatal
overdoses but also provide essential prevention informa-
tion that could help to reduce the prevalence of all over-
doses.
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